Saturday 17 October 2026 Export TVTX’s income statement to Excel — free account

Travere Therapeutics, Inc.

Travere Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $490.7 million, up 110.5% from fiscal 2024. In the quarter to June 2026, revenue grew 48.2%, EPS fell 164.3%, free cash flow grew 604.2% and total debt rose 93.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

49.62 3.17 −6.00%

Follow TVTX

Alert me

Market cap: $5.0B
P/E: 0.0×
Fwd P/E: 196×
Dividend yield: —
F-score: 6/9
Altman Z: 1.78
Beneish M: −1.74
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	8.98	5.09	6.95	4.89
P/FCF ratio Full definition →	366.95	0.00	0.00	0.00
P/Operating CF Full definition →	91.45	(67.62)	56.18	148.96
P/B ratio Full definition →	216.56	27.65	29.69	28.99
Price to Tangible BV Full definition →	0.00	0.00	3,550.82	0.00
EV/Sales Full definition →	9.17	5.18	6.92	5.02
EV/EBITDA Full definition →	269.67	208.91	0.00	0.00
EV/Operating CF Full definition →	58.51	70.10	89.92	(37.35)
EV/FCF Full definition →	374.80	(93.71)	(161.30)	(20.30)
Quick Ratio Full definition →	3.75	2.81	2.52	2.50
Current Ratio Full definition →	4.05	3.13	2.74	2.75
Net Debt/EBITDA Full definition →	13.87	(4.05)	0.65	1.40
Debt/Assets Full definition →	75.41%	56.21%	51.51%	57.81%
Debt/Equity Full definition →	24.58	3.16	2.71	4.23
Asset Turnover Full definition →	0.87	0.97	0.82	0.84
Operating CF/Net income Full definition →	(1.67)	1.09	22.23	0.56
Capex/Depreciation Full definition →	(4.98)	(0.88)	(1.25)	(0.98)
Interest Coverage Full definition →	1.85	(16.05)	(14.14)	9.06
Research and Development Expense of Revenue Full definition →	35.55%	44.89%	44.62%	31.48%
Selling, General and Administrative Expense of Revenue Full definition →	56.68%	63.09%	98.51%	52.44%
Intangible Assets out of Total Assets Full definition →	0.16	0.20	0.19	0.20
Share Based Compensation of Revenue Full definition →	12.85%	12.69%	8.84%	6.83%
Graham Net Nets Full definition →	(0.03)	(0.02)	(0.02)	(0.04)
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(0.79%)	(0.74%)	(0.76%)	(4.39%)
Free Cash Flow Yield Full definition →	0.27%	(1.09%)	(0.62%)	(5.06%)
Revenue per Share Full definition →	1.81	1.38	1.45	1.85
Operating CF per Share Full definition →	0.62	(0.44)	0.68	0.16
Capex per Share Full definition →	(0.23)	(0.24)	(0.22)	(0.17)
Free Cash Flow per Share Full definition →	0.40	(0.68)	0.46	(0.01)
Cash per Share Full definition →	5.23	2.88	3.62	2.85
Shareholders Equity per Share Full definition →	0.26	1.07	1.29	0.82
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.26	1.07	1.29	0.82
Free Cash Flow Full definition →	37.00	(62.54)	41.44	(1.11)
Working Capital Full definition →	463.12	267.24	277.66	236.04
Capital Expenditures Full definition →	(21.07)	(22.18)	(19.24)	(15.42)
Net Current Asset Value Full definition →	(159.70)	(63.78)	(52.80)	(93.91)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.12	0.17	0.15	0.09
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	59.68	60.84	53.63	54.08
Average Payables Full definition →	13.31	14.14	24.17	20.71
Average Inventory Full definition →	5.96	5.14	6.04	5.95
Average Assets Full definition →	677.33	551.99	599.66	521.50
Average Common Equity Full definition →	28.63	65.78	86.95	21.56

Show all line items

Columns are period end dates

Stockrow Weekly